HUMAN ACID BETA-GLUCOSIDASE - NORTHERN BLOT AND S1 NUCLEASE ANALYSIS OF MESSENGER-RNA FROM HELA-CELLS AND NORMAL AND GAUCHER DISEASE FIBROBLASTS
- 1 December 1986
- journal article
- research article
- Vol. 39 (6) , 763-774
Abstract
Human acid .beta.-glucosidase (.beta.-Glc) mRNA was evaluated by dot blot, Northern blot, and S1 nuclease analyses of extracts of HeLa cells and cultured fibroblasts from normal individuals and Gaucher disease patients. Dot blot quantitation indicated and equal concentration of specific mRNA in all sources. Northern blot analyses demonstrated the presence of three poly (A)+ mRNAs of about 5,600, 2,500, and 2,000 nucleotides in length from all cell extracts. All three mRNAs were present in normal amounts in fibroblast extracts from several subtypes and variants of Gaucher disease. The largest poly (A)+ mRNA species was thought to represent an unspliced nuclear precursor for the two smaller .beta.-Glc mRNAs. S1 nuclease analyses, using SP6 transcripts of .beta.-Glc cDNA, indicated that the 2,000 nucleotide mRNA differs from the 2,500 nucleotide form at both the 5'' and 3'' ends. These results are consistent with the use of an alternate 5'' splice site and 3'' polyadenylation signal. These results also suggest that the subtype and variants of Gaucher disease result from single base alterations that lead to the synthesis of defective .beta.-Glc.This publication has 25 references indexed in Scilit:
- Molecular cloning and nucleotide sequence of human glucocerebrosidase cDNA.Proceedings of the National Academy of Sciences, 1985
- Peptide diversity from exon choice: RNA processing regulation in the neuroendocrine systemMolecular and Cellular Endocrinology, 1985
- Genetic heterogeneity in Gaucher disease: Physicokinetic and immunologic studies of the residual enzyme in cultured fibroblasts from non‐neuronopathic and neuronopathic patientsAmerican Journal of Medical Genetics, 1985
- Role of the Conserved AAUAAA Sequence: Four AAUAAA Point Mutants Prevent Messenger RNA 3′ End FormationScience, 1984
- Characterization of mouse ribosomal gene fragments purified by molecular cloningGene, 1979
- Non-neuropathic Gaucher disease presenting in infancy.Archives of Disease in Childhood, 1979
- Labeling deoxyribonucleic acid to high specific activity in vitro by nick translation with DNA polymerase IJournal of Molecular Biology, 1977
- Polyadenylic Acid Segment in mRNA Becomes Shorter with AgeNature New Biology, 1973
- Purification and properties of the replicative intermediate of the RNA bacteriophage R17.Proceedings of the National Academy of Sciences, 1966
- GAUCHER'S DISEASE IN 29 CASES: HEMATOLOGIC COMPLICATIONS AND EFFECT OF SPLENECTOMYAnnals of Internal Medicine, 1954